216 related articles for article (PubMed ID: 18941886)
21. The efficacy of modified luteal phase support with intramuscular progesterone in IVF/ICSI cycles: a retrospective observational study.
Conforti A; Strina I; Mollo A; Amoroso R; Marrone V; Alviggi C; Marci R; de Placido G
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):657-661. PubMed ID: 28272720
[TBL] [Abstract][Full Text] [Related]
22. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
[TBL] [Abstract][Full Text] [Related]
23. Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation.
Doody KJ; Schnell VL; Foulk RA; Miller CE; Kolb BA; Blake EJ; Yankov VI
Fertil Steril; 2009 Apr; 91(4):1012-7. PubMed ID: 18371963
[TBL] [Abstract][Full Text] [Related]
24. Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome.
Ragni G; Vegetti W; Riccaboni A; Engl B; Brigante C; Crosignani PG
Hum Reprod; 2005 Sep; 20(9):2421-5. PubMed ID: 15890731
[TBL] [Abstract][Full Text] [Related]
25. Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer.
Drakakis P; Loutradis D; Vomvolaki E; Stefanidis K; Kiapekou E; Anagnostou E; Anastasiadou K; Milingos S; Antsaklis A
Gynecol Endocrinol; 2007 Nov; 23(11):645-52. PubMed ID: 17999276
[TBL] [Abstract][Full Text] [Related]
26. GnRH antagonists in ovarian stimulation for IVF.
Tarlatzis BC; Fauser BC; Kolibianakis EM; Diedrich K; Rombauts L; Devroey P
Hum Reprod Update; 2006; 12(4):333-40. PubMed ID: 16567347
[TBL] [Abstract][Full Text] [Related]
27. Vaginal progesterone gel for luteal phase support in IVF/ICSI cycles: a meta-analysis.
Polyzos NP; Messini CI; Papanikolaou EG; Mauri D; Tzioras S; Badawy A; Messinis IE
Fertil Steril; 2010 Nov; 94(6):2083-7. PubMed ID: 20171629
[TBL] [Abstract][Full Text] [Related]
28. Luteal phase support in in vitro fertilization.
Yanushpolsky EH
Semin Reprod Med; 2015 Mar; 33(2):118-27. PubMed ID: 25734349
[TBL] [Abstract][Full Text] [Related]
29. Effect of Gonadotrophin-Releasing Hormone Agonist Addition for Luteal Support on Pregnancy Outcome in vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: A Meta-Analysis Based on Randomized Controlled Trials.
Ma X; Du W; Hu J; Yang Y; Zhang X
Gynecol Obstet Invest; 2020; 85(1):13-25. PubMed ID: 31422404
[TBL] [Abstract][Full Text] [Related]
30. Luteal phase support with estrogen in addition to progesterone increases pregnancy rates in in vitro fertilization cycles with poor response to gonadotropins.
Kutlusoy F; Guler I; Erdem M; Erdem A; Bozkurt N; Biberoglu EH; Biberoglu KO
Gynecol Endocrinol; 2014 May; 30(5):363-6. PubMed ID: 24517720
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
[TBL] [Abstract][Full Text] [Related]
32. Luteal phase defects in assisted reproduction: the role of luteal phase supplementation.
Capitanio GL; Ubaldi F; Giannini P; Croce S
Acta Eur Fertil; 1992; 23(1):15-9. PubMed ID: 1293894
[TBL] [Abstract][Full Text] [Related]
33. GnRH agonist plus vaginal progesterone for luteal phase support in ICSI cycles: a randomized study.
Aboulghar MA; Marie H; Amin YM; Aboulghar MM; Nasr A; Serour GI; Mansour RT
Reprod Biomed Online; 2015 Jan; 30(1):52-6. PubMed ID: 25456166
[TBL] [Abstract][Full Text] [Related]
34. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.
Mui Lam P; Chun Cheung M; Ping Cheung L; Ingrid Lok H; John Haines C
Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535
[TBL] [Abstract][Full Text] [Related]
35. Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization.
Hsieh YY; Chang CC; Tsai HD
Taiwan J Obstet Gynecol; 2008 Mar; 47(1):66-74. PubMed ID: 18400585
[TBL] [Abstract][Full Text] [Related]
36. GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial.
Fusi FM; Brigante CM; Zanga L; Mignini Renzini M; Bosisio C; Fadini R
Reprod Biol Endocrinol; 2019 Nov; 17(1):103. PubMed ID: 31783862
[TBL] [Abstract][Full Text] [Related]
37. Luteal phase support with estradiol and progesterone versus progesterone alone in GnRH antagonist ICSI cycles: a randomized controlled study.
Ismail Madkour WA; Noah B; Abdel Hamid AM; Zaheer H; Al-Bahr A; Shaeer M; Moawad A
Hum Fertil (Camb); 2016 Jun; 19(2):142-9. PubMed ID: 27434094
[TBL] [Abstract][Full Text] [Related]
38. GnRH agonist versus GnRH antagonist in controlled ovarian hyperstimulation: their role in patients with an unfavorable prognosis a priori.
Orvieto R; Homburg R; Meltcer S; Rabinson J; Anteby EY; Scharf S
Fertil Steril; 2009 Apr; 91(4 Suppl):1378-80. PubMed ID: 18675972
[TBL] [Abstract][Full Text] [Related]
39. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
40. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists.
Kolibianakis EM; Schultze-Mosgau A; Schroer A; van Steirteghem A; Devroey P; Diedrich K; Griesinger G
Hum Reprod; 2005 Oct; 20(10):2887-92. PubMed ID: 15979994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
